Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00182715
What this trial is testing

Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Velindre NHS Trust 2,421
Testing effectiveness (Phase 2)Ended earlyNCT01605318
What this trial is testing

Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerColon CancerRectal Cancer
Gilead Sciences 92
Early research (Phase 1)Study completedNCT00023933
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+3 more
National Cancer Institute (NCI) 15
Large-scale testing (Phase 3)Study completedNCT01169558
What this trial is testing

Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 168
Testing effectiveness (Phase 2)Study completedNCT00016978
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04793958
What this trial is testing

Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

Who this might be right for
Advanced Colorectal CancerMetastatic Colorectal Cancer
Mirati Therapeutics Inc. 461
Testing effectiveness (Phase 2)Study completedNCT00541125
What this trial is testing

G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 20
Testing effectiveness (Phase 2)Study completedNCT00016952
What this trial is testing

Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 19
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT01383343
What this trial is testing

Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Rectal CarcinomaStage IVA Colon Cancer+3 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00005085
What this trial is testing

Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT01111838
What this trial is testing

Clinical and Translational Study of STA-9090

Who this might be right for
Colon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00098787
What this trial is testing

Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group 247
Large-scale testing (Phase 3)UnknownNCT00002893
What this trial is testing

Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Medical Research Council 900
Testing effectiveness (Phase 2)Study completedNCT00655499
What this trial is testing

Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 65
Not applicableUnknownNCT05873621
What this trial is testing

Indocyanine Green-guided Lymphadenectomy in Laparoscopic Total Mesorectal Excision for Low Rectal Cancer After Neoadjuvant Chemoradiotherapy

Who this might be right for
Rectal CancerLymph Node Cancer Metastatic
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 60
Not applicableEnded earlyNCT01544452
What this trial is testing

Total Preoperative MR Diagnostic Evaluation Versus Standard Diagnostic Evaluation in Patients With Rectal Cancer

Who this might be right for
Rectal CancerLiver Metastasis
Herlev Hospital 75
Testing effectiveness (Phase 2)Study completedNCT01116687
What this trial is testing

RO4929097 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
National Cancer Institute (NCI) 37
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)UnknownNCT05022030
What this trial is testing

First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes

Who this might be right for
Colo-rectal CancerCapecitabineCetuximab
West China Hospital 150
Next Page